Avatar Intervention for Cannabis Use Disorder in a Patient with Schizoaffective Disorder: A Case Report

Author:

Giguère Sabrina12,Dellazizzo Laura12ORCID,Beaudoin Mélissa123ORCID,Lapierre Marie-Andrée1,Villeneuve Marie14,Phraxayavong Kingsada1ORCID,Potvin Stéphane12ORCID,Dumais Alexandre125ORCID

Affiliation:

1. Research Center of the Institut Universitaire en Santé Mentale de Montréal, Montreal, QC H1N 3V2, Canada

2. Department of Psychiatry and Addictology, Faculty of Medicine, Université de Montréal, Montreal, QC H3T 1J4, Canada

3. Faculty of Medicine, University of McGill, Montreal, QC H3A 0G4, Canada

4. Institut Universitaire en Santé Mentale de Montréal, Montreal, QC H1N 3M5, Canada

5. Institut National de Psychiatrie Légale Philippe-Pinel, Montreal, QC H1C 1H1, Canada

Abstract

Considering the harmful effects of cannabis on individuals with a severe mental disorder and the limited effectiveness of current interventions, this case report showcases the beneficial results of a 10-session Avatar intervention for cannabis use disorder (CUD) on a polysubstance user with a comorbid schizoaffective disorder. Virtual reality allowed the creation of an Avatar representing a person significantly related to the patient’s drug use. Avatar intervention for CUD aims to combine exposure, relational, and cognitive behavioral therapies while practicing real-life situations and learning how to manage negative emotions and cravings. Throughout therapy and later on, Mr. C managed to maintain abstinence from all substances. Also, an improvement in the severity of CUD, as well as a greater motivation to change consumption, was observed after therapy. As observed by his mother, his psychiatrist, and himself, the benefits of Avatar intervention for CUD extended to other spheres of his life. The drastic results observed in this patient could be promising as an alternative to the current treatment available for people with a dual diagnosis of cannabis use disorder and psychotic disorder, which generally lack effectiveness. A single-blind randomized control trial comparing the treatment with a classical intervention in a larger sample is currently underway to evaluate whether the results are reproducible on a larger sample.

Funder

Fondation Lévesque

Services et recherches psychiatriques AD

IRSC Catalyseur

Publisher

MDPI AG

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3